Showing results (631-640 of 687) with videos related to
Sort By:
Pageof 69
Epilepsy & Behavior : E&B|December 6, 2020
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsySimona Balestrini, Matthias J Koepp, Sonia Gandhi, et al.Journal of Bronchology & Interventional Pulmonology|May 29, 2023
Spray Cryotherapy for Benign Large Airway Stenosis: A Multicenter Retrospective Cohort Study of Safety and Practice PatternsAnkush P Ratwani, Robert J Lentz, Heidi Chen, et al.International Journal of Cancer|September 21, 2011
Oncogenic PIK3CA mutations in colorectal cancers and polypsVicki L J Whitehall, Celestine Rickman, Catherine E Bond, et al.Science Translational Medicine|March 22, 2019
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancerLoredana Puca, Katie Gavyert, Verena Sailer, et al.Research Square|February 26, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.Lung Cancer (Amsterdam, Netherlands)|December 25, 2012
Randomized phase II trial of sulindac for lung cancer chemopreventionPaul J Limburg, Sumithra J Mandrekar, Marie Christine Aubry, et al.Experimental Astronomy|June 8, 2022
Exploring the link between star and planet formation with ArielDiego Turrini, Claudio Codella, Camilla Danielski, et al.Nature Communications|August 8, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.Epigenomics|September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directionsYuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.Elife|December 13, 2022
Defining cellular population dynamics at single-cell resolution during prostate cancer progressionAlexandre A Germanos, Sonali Arora, Ye Zheng, et al.Pageof 69